BioSpace News Archive

Evozyne today revealed a breakthrough AI model, developed in collaboration with NVIDIA, that the pharmaceutical industry can use to design therapeutic proteins.

Global health services company Cigna Corporation (NYSE:CI) will release its fourth quarter 2022 financial results on Friday, February 3, 2023, and will host a conference call the same day.

Today, Two Labs, an industry-leading pharma services company, is announcing the launch of its REMS strategy and program management offerings, which will be provided by its Shepherd Safety Services team.

TetraScience, the Scientific Data Cloud company, announced today that Labforward, a leader in optimizing laboratory workflows, has joined the Tetra Partner Network to enable scientists to maximize the value of their data utilizing the Tetra Scientific Data Cloud™.

Neutron Therapeutics (NT) today announced the successful production of a proton beam at an industry-leading 37mA of proton current on target, and the generation of the first neutron beam at its nuBeam® system at Shonan Kamakura General Hospital (SKGH) in Kanagawa Prefecture, Japan.

ViewRay, Inc. (NASDAQ: VRAY) today announced that findings from the phase III randomized controlled MIRAGE trial (NCT04384770) were published on January 12 in JAMA Oncology.

Hoag Memorial Hospital Presbyterian recently became the first hospital in Southern California and one of only a handful of hospitals in the world to provide patients with access to a clinical trial that is poised to change the face of cancer treatment.

Paxlovid (nirmatrelvir with ritonavir) has been shown in clinical studies to be a highly-effective treatment to mitigate the severity of a COVID-19 infection—with some studies showing it can be close to 90% effective in reducing the risk of severe disease, and in reducing hospitalization for people age 65 and over.

BIOLASE, Inc., the global leader in dental lasers, announced that the Company has been awarded a Top Workplaces 2022 honor by the Orange County Register Top Workplaces.

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its fourth quarter and full year 2022 financial results, as well as on its financial guidance for 2023, on Wednesday, February 8, 2023 at 7:00 a.m. ET.